Randomized Controlled Clinical Trial of "Virtual House Calls" for Parkinson Disease

被引:163
|
作者
Dorsey, E. Ray [1 ]
Venkataraman, Vinayak [1 ]
Grana, Matthew J. [3 ]
Bull, Michael T. [3 ]
George, Benjamin P. [6 ]
Boyd, Cynthia M. [2 ]
Beck, Christopher A. [4 ]
Rajan, Balaraman [5 ]
Seidmann, Abraham [5 ]
Biglan, Kevin M. [3 ]
机构
[1] Johns Hopkins Med, Dept Neurol, Baltimore, MD 21287 USA
[2] Johns Hopkins Med, Dept Med, Baltimore, MD 21287 USA
[3] Univ Rochester, Med Ctr, Dept Neurol, New York, NY USA
[4] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, New York, NY USA
[5] Univ Rochester, William E Simon Grad Sch Business Adm, New York, NY USA
[6] Univ Rochester, Sch Med & Dent, New York, NY USA
关键词
DEEP-BRAIN-STIMULATION; CARE; TELEMEDICINE; SATISFACTION; VALIDATION;
D O I
10.1001/jamaneurol.2013.123
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Importance: The burden of neurological disorders is increasing, but access to care is limited. Providing specialty care to patients via telemedicine could help alleviate this growing problem. Objective: To evaluate the feasibility, effectiveness, and economic benefits of using web-based videoconferencing (telemedicine) to provide specialty care to patients with Parkinson disease in their homes. Design: A 7-month, 2-center, randomized controlled clinical trial. Setting: Patients' homes and outpatient clinics at 2 academic medical centers. Participants: Twenty patients with Parkinson disease with Internet access at home. Intervention: Care from a specialist delivered remotely at home or in person in the clinic. Main Outcome Measures: The primary outcome variable was feasibility, as measured by the percentage of telemedicine visits completed as scheduled. Secondary outcome measures included clinical benefit, as measured by the 39-item Parkinson Disease Questionnaire, and economic value, as measured by time and travel. Results: Twenty participants enrolled in the study and were randomly assigned to telemedicine (n=9) or in-person care (n=11). Of the 27 scheduled telemedicine visits, 25 (93%) were completed, and of the 33 scheduled in-person visits, 30 (91%) were completed (P=.99). In this small study, the change in quality of life did not differ for those randomly assigned to telemedicine compared with those randomly assigned to in-person care (4.0-point improvement vs 6.4-point improvement; P=.61). Compared with in-person visits, each telemedicine visit saved participants, on average, 100 miles of travel and 3 hours of time. Conclusion and Relevance: Using web-based videoconferencing to provide specialty care at home is feasible, provides value to patients, and may offer similar clinical benefit to that of in-person care. Larger studies are needed to determine whether the clinical benefits are indeed comparable to those of in-person care and whether the results observed are generalizable.
引用
收藏
页码:565 / 570
页数:6
相关论文
共 50 条
  • [31] Effects of Nordic walking training on functional parameters in Parkinson's disease: a randomized controlled clinical trial
    Monteiro, E. P.
    Franzoni, L. T.
    Cubillos, D. M.
    de Oliveira Fagundes, A.
    Carvalho, A. R.
    Oliveira, H. B.
    Pantoja, P. D.
    Schuch, F. B.
    Rieder, C. R.
    Martinez, F. G.
    Peyre-Tartaruga, L. A.
    SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 2017, 27 (03) : 351 - 358
  • [32] The effect of the Mediterranean diet on cognitive function in patients with Parkinson's disease: A randomized clinical controlled trial
    Paknahad, Zamzam
    Sheklabadi, Elham
    Derakhshan, Yeganeh
    Bagherniya, Mohammad
    Chitsaz, Ahmad
    COMPLEMENTARY THERAPIES IN MEDICINE, 2020, 50
  • [33] Patient Education for Patients with Parkinson's Disease - A Randomized Controlled Trial
    Magdalena, Chlond
    Felicitas, Bergmann
    Heike, Schnoor
    Karla, Eggert
    Astrid, Larisch
    ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE, 2013, 59 (01): : 68 - 69
  • [34] Caffeine as a treatment for Parkinson's disease: A randomized controlled trial (CafePD)
    Postuma, R.
    Anang, J.
    Pelletier, A.
    Moscovich, M.
    Grimes, D.
    Borys, A.
    Furtado, S.
    Munhoz, R.
    Cresswell, S.
    Moro, A.
    Hobson, D.
    Joseph, L.
    Lang, A.
    MOVEMENT DISORDERS, 2017, 32
  • [35] Randomized controlled trial of the Alexander Technique for idiopathic Parkinson's disease
    Stallibrass, C
    Sissons, P
    Chalmers, C
    CLINICAL REHABILITATION, 2002, 16 (07) : 695 - 708
  • [36] Speech treatment in Parkinson's disease: Randomized controlled trial (RCT)
    Ramig, Lorraine
    Halpern, Angela
    Spielman, Jennifer
    Fox, Cynthia
    Freeman, Katherine
    MOVEMENT DISORDERS, 2018, 33 (11) : 1777 - 1791
  • [37] A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease
    Shoulson, I
    Penney, J
    McDermott, M
    Kieburtz, K
    Schwid, SR
    Kayson, E
    Chase, T
    Fahn, S
    Greenamyre, JT
    Lang, A
    Siderowf, A
    Pearson, N
    Harrison, M
    Rost-Ruffner, E
    Colcher, A
    Lloyd, M
    Matthews, M
    Pahwa, R
    McGuire, D
    Lew, MF
    Schuman, S
    Marek, K
    Broshjeit, S
    Factor, S
    Brown, D
    Feigin, A
    Mazurkiewicz, J
    Ford, B
    Jennings, D
    Dillon, S
    Comella, C
    Blasucci, L
    Janko, K
    Shulman, L
    Wiener, W
    Bateman-Rodriguez, D
    Carrion, A
    Suchowersky, O
    Lafontaine, AL
    Pantella, C
    Siemers, E
    Belden, J
    Davies, R
    Lannon, M
    Grimes, D
    Gray, P
    Martin, W
    Kennedy, L
    Adler, C
    Newman, S
    NEUROLOGY, 2001, 56 (04) : 455 - 462
  • [38] Effects of cognitive training in Parkinson's disease: A randomized controlled trial
    Petrelli, Annette
    Kaesberg, Stephanie
    Barbe, Michael T.
    Timmermann, Lars
    Fink, Gereon R.
    Kessler, Josef
    Kalbe, Elke
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (11) : 1196 - 1202
  • [39] Improving Prospective Memory in Persons With Parkinson Disease: A Randomized Controlled Trial
    Foster, Erin R.
    McDaniel, Mark A.
    Rendell, Peter G.
    NEUROREHABILITATION AND NEURAL REPAIR, 2017, 31 (05) : 451 - 461
  • [40] Improving functional disability and cognition in Parkinson disease Randomized controlled trial
    Pena, Javier
    Ibarretxe-Bilbao, Naroa
    Garcia-Gorostiaga, Ines
    Angeles Gomez-Beldarrain, Maria
    Diez-Cirarda, Maria
    Ojeda, Natalia
    NEUROLOGY, 2014, 83 (23) : 2167 - 2174